clinical dermatology

New topical hemostatic device in pipelineIf cleared, dermatologists might find the technology useful when excising lesions in patients on blood thinners and more.
Topical agents for acneWhen it comes to choosing topical agents for treating acne, separating fact from fiction can be challenging for dermatologists.
Oral antibiotics for acneDermatologists should turn to oral antibiotics for treating acne when topical medications have failed or are too irritating.
Therapies for hidradenitis suppurativaAlthough hidradenitis suppurativa is a disease that is extremely impactful and burdensome several medical therapies have been proven to be effective and safe.
Accelerating skin disease researchAvailable resources of the Center include human pathology specimens and database info on living consented patients. Techniques such as tissue imaging, gene expression analysis, T-cell receptor, sequencing studies, and CyTOF analyses are available. Visiting Scholar grants funds allow researchers to learn how to work with human tissue and how to use new techniques.
Targeted treatments for atopic dermatitisEmerging treatments are expected to help fill the need for safer and more effective therapies for atopic dermatitis (AD). Both systemic and topical treatments are needed to provide full and complete treatment for patients with AD. Targeting the specific axis or axes that control AD may contribute to developing personalized approaches to treatment
Therapies for hidradenitis suppurativaTNF inhibitors adalimumab and infliximab have evidence-based efficacy for the treatment of hidradentitis suppurativa (HS). Anti-interleukin inhibitors ustekinumab and anakinra also being evaluated in small studies for treatment of HS. Antibiotics, hormones, retinoids, steroids and laser therapies directly targeting the lesions round out an effective treatment plan for HS patients.
Understanding and using biosimilarsBiosimilars have the potential to lower the high costs of biologic treatments for patients suffering from chronic skin diseases. Although biosimilars have received FDA approval derms still have many questions about what they are and when they may be used appropriately. Patent wars and a lack of rules and regulations at the state level add to the confusion about using biosimilars.
March Clinical Considerations for NPs, PAsThis month we’re looking at some allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulaters.
The future of wound healing
The future of wound healingResearchers have developed a 3D printer that applies skin cells onto burn wounds. Bio-printed cells enhanced wound healing by three to four weeks compared with untreated or matrix-treated wounds. Researchers are compiling animal data to submit an IND application for a clinical trial.